Latest Developments in the Management of AMD

Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):477-478. doi: 10.22608/APO.2017480.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Complement C3 / antagonists & inhibitors
  • Complement Inactivating Agents / therapeutic use
  • Geographic Atrophy / drug therapy*
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Wet Macular Degeneration / drug therapy*

Substances

  • Angiogenesis Inhibitors
  • Complement C3
  • Complement Inactivating Agents
  • Immunoglobulin Fab Fragments
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • lampalizumab